VETTER-JECT Trademark

Trademark Overview


On Monday, September 24, 2018, a trademark application was filed for VETTER-JECT with the United States Patent and Trademark Office. The USPTO has given the VETTER-JECT trademark a serial number of 79250207. The federal status of this trademark filing is REGISTERED as of Tuesday, July 19, 2022. This trademark is owned by Vetter Pharma-Fertigung GmbH & Co. KG. The VETTER-JECT trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:

Bottling services, namely, bottling of liquid and solid substances, in particular of pharmaceuticals, medicines and solutions

Pharmaceutical preparations and medicines for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; pharmaceutical solutions for oral administration in the nature of sterile aseptic solutions, namely in the form of tablets, pills, capsules, drops, medical juice and medical syrup, all for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and ...

Empty medical injection devices, in particular syringes and instruments for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes, all sold empty; medicine containers for administering medicines, of glass and/or plastic in the nature of medical syringes, injectors, auto-injectors, disposable syringes and disposable cannulae; syringe holders being containers specially adapted for holding medical syringes; medical syringes, disposable syringes, and disposable cannulae sold either individually or in combination, all for medical purposes

Development of syringes and instruments for injections, injectors and packaging for the aforesaid goods; laboratory tests in the nature of scientific testing in the fields of chemical, physics and process engineering; product development and conducting of scientific tests in the fields of pharmacological and microbiological processes
vetter-ject

General Information


Serial Number79250207
Word MarkVETTER-JECT
Filing DateMonday, September 24, 2018
Status700 - REGISTERED
Status DateTuesday, July 19, 2022
Registration Number6791709
Registration DateTuesday, July 19, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2022

Trademark Statements


Goods and ServicesBottling services, namely, bottling of liquid and solid substances, in particular of pharmaceuticals, medicines and solutions
Goods and ServicesPharmaceutical preparations and medicines for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; pharmaceutical solutions for oral administration in the nature of sterile aseptic solutions, namely in the form of tablets, pills, capsules, drops, medical juice and medical syrup, all for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; injectable pharmaceuticals in the nature of antibody solutions, biologicals, peptides, polypeptides, proteins, enzymes, nucleic acids, coagulation factors, interferons, phosphonates and bisphosphonates, growth factors, hormones, hormoneantagonists, insulin, heparins, low molecular heparins and sulfur hexafluoride, all for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction, inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia; eyedrops, contact lens solutions; medicated compresses; medical plasters, materials for dressings in the nature of bandages, wadding and gauze; filled medical injection devices, in particular syringes and instruments for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes, all sold filled with pharmaceutical preparations for the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial disfunction, liver disfunction inflammation and inflammatory diseases, oral and laryngeal disease, optical and cranial disorders, arthritis, migraine, mucopolysaccharidosis, haemophilia, multiple sclerosis, osteoporosis, neuronal disorders, diabetes, erectile disfunction, infertility, crohn's disease, hereditary angioedema, thrombosis, encephalitis, diseases of the thyroid or parathyroid glands, metabolic diseases, muscular atrophy, disturbance of growth and anemia
Pseudo MarkVETTER-INJECT
Goods and ServicesEmpty medical injection devices, in particular syringes and instruments for injections, injectors, auto-injectors and single-chamber and dual-chamber disposable syringes, all sold empty; medicine containers for administering medicines, of glass and/or plastic in the nature of medical syringes, injectors, auto-injectors, disposable syringes and disposable cannulae; syringe holders being containers specially adapted for holding medical syringes; medical syringes, disposable syringes, and disposable cannulae sold either individually or in combination, all for medical purposes
Goods and ServicesDevelopment of syringes and instruments for injections, injectors and packaging for the aforesaid goods; laboratory tests in the nature of scientific testing in the fields of chemical, physics and process engineering; product development and conducting of scientific tests in the fields of pharmacological and microbiological processes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, January 28, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateMonday, January 28, 2019
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 28, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVetter Pharma-Fertigung GmbH & Co. KG
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressDE

Party NameVetter Pharma-Fertigung GmbH & Co. KG
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressDE

Party NameVetter Pharma-Fertigung GmbH & Co. KG
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressDE

Trademark Events


Event DateEvent Description
Monday, November 14, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, October 22, 2022FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 22, 2022FINAL DISPOSITION PROCESSED
Wednesday, October 19, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 19, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 19, 2022REGISTERED-PRINCIPAL REGISTER
Monday, May 9, 2022NOTIFICATION PROCESSED BY IB
Tuesday, May 3, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 13, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, March 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 25, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, September 27, 2021NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, September 27, 2021CONTINUATION OF FINAL REFUSAL E-MAILED
Monday, September 27, 2021ACTION CONTINUING A FINAL - COMPLETED
Wednesday, July 28, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Sunday, May 16, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, October 2, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 12, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2020LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2020SUSPENSION LETTER WRITTEN
Tuesday, March 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 10, 2020ASSIGNED TO LIE
Wednesday, March 4, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, March 5, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 5, 2020LETTER OF SUSPENSION E-MAILED
Thursday, March 5, 2020SUSPENSION LETTER WRITTEN
Friday, December 6, 2019CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, November 29, 2019CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, September 5, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 5, 2019FINAL REFUSAL E-MAILED
Thursday, September 5, 2019FINAL REFUSAL WRITTEN
Tuesday, August 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 2, 2019REFUSAL PROCESSED BY IB
Wednesday, February 13, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 12, 2019REFUSAL PROCESSED BY MPU
Tuesday, February 5, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 4, 2019NON-FINAL ACTION WRITTEN
Friday, February 1, 2019APPLICATION FILING RECEIPT MAILED
Monday, January 28, 2019ASSIGNED TO EXAMINER
Monday, January 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 24, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB